Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
BLACKROCK INC BLK |
5,872,642 5.300% |
408,663 (+7.48%) |
Filing History |
| 2024-11-14 4:30 pm Sale |
2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 721,926 0.600% |
-4,423,186 (-85.97%) |
Filing History |
| 2024-11-12 5:54 pm Unchanged |
2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX |
The Vanguard Group | 10,167,614 9.170% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:54 pm Purchase |
2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX |
The Vanguard Group | 10,167,614 9.170% |
4,785,710 (+88.92%) |
Filing History |
| 2024-10-18 12:26 pm Sale |
2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX |
STATE STREET CORP STT |
4,666,157 4.200% |
-1,066,833 (-18.61%) |
Filing History |
| 2024-08-07 4:10 pm Sale |
2024-07-31 | 13G | Viking Therapeutics, Inc. VKTX |
BLACKROCK INC BLK |
5,463,979 4.900% |
-2,141,888 (-28.16%) |
Filing History |
| 2024-02-14 10:13 am Sale |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% |
-713,420 (-12.18%) |
Filing History |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Viking Therapeutics, Inc. VKTX |
The Vanguard Group | 5,381,904 5.380% |
5,381,904 (New Position) |
Filing History |
| 2024-02-09 10:05 am Purchase |
2024-02-08 | 13G | Viking Therapeutics, Inc. VKTX |
FMR CORP | 15,004,340 14.999% |
4,081,593 (+37.37%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
BLACKROCK INC BLK |
7,605,867 7.600% |
6,178,646 (+432.91%) |
Filing History |
| 2024-01-24 1:24 pm Purchase |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
STATE STREET CORP STT |
5,732,990 5.730% |
5,486,148 (+2222.53%) |
Filing History |
| 2024-01-12 4:26 pm Sale |
2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
MILLENNIUM MANAGEMENT LLC | 403,556 0.400% |
-4,425,644 (-91.64%) |
Filing History |
| 2023-11-02 4:30 pm Purchase |
2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% |
5,858,532 (New Position) |
Filing History |
| 2023-04-10 09:37 am Purchase |
2023-04-06 | 13G | Viking Therapeutics, Inc. VKTX |
FMR CORP | 10,922,747 11.418% |
8,736,380 (+399.58%) |
Filing History |
| 2023-03-30 4:08 pm Sale |
2023-03-28 | 13D | Viking Therapeutics, Inc. VKTX |
LIGAND PHARMACEUTICALS INC LGND |
3,616,077 4.600% |
-2,449,003 (-40.38%) |
Filing History |
| 2023-02-14 5:28 pm Sale |
2021-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
ArrowMark Colorado Holdings LLC | 15,931 0.020% |
-7,044,872 (-99.77%) |
Filing History |
| 2023-02-09 4:30 pm Sale |
2023-02-06 | 13D | Viking Therapeutics, Inc. VKTX |
LIGAND PHARMACEUTICALS INC LGND |
6,065,080 7.900% |
-1,274,303 (-17.36%) |
Filing History |
| 2023-02-03 3:36 pm Sale |
2022-12-31 | 13G | Viking Therapeutics, Inc. VKTX |
STATE STREET CORP STT |
246,842 0.320% |
-3,878,725 (-94.02%) |
Filing History |
| 2023-01-03 4:51 pm Purchase |
2022-12-23 | 13G | Viking Therapeutics, Inc. VKTX |
MILLENNIUM MANAGEMENT LLC | 4,829,200 6.300% |
4,829,200 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Viking Therapeutics, Inc. VKTX |
BLACKROCK INC BLK |
1,427,221 1.800% |
-3,692,269 (-72.12%) |
Filing History |